COMP <GO>
PROF vs UTMD // 10Y YIELD & FRED MACRO BETA
Profound Medical Corp. (NASDAQ) VS. Utah Medical Products Inc. (NASDAQ) • 15-METRIC TALLY: PROF 5
— UTMD 4
■ METRIC PARITY
LAST: $5.86 (+1.38%) • MKT CAP: $214.1M
macro-sensitivity
—
LAST: $66.80 (-2.96%) • MKT CAP: $212.7M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. UTMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PROF | UTMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.80% | 57.10% | +13.70 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 26.90% | -61.90 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.93% | 6.73% | -24.66 | UTMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | 29.60% | -89.60 | UTMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | -5.80% | +71.10 | PROF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.87% | -1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | PROF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.7 | 30.1 | +28.58 | PROF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $214.1M | $212.7M | $1.4M | PROF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PROF REV | UTMD REV | PROF GROSS % | UTMD GROSS % | PROF FCF | UTMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.1M | $38.5M | 70.8% | 57.1% | -$38.4M | $14.3M |
| FY 2024 | $9.7M | $40.9M | 72.2% | 59.0% | -$23.5M | $14.6M |
| FY 2023 | $5.9M | $50.2M | — | — | -$22.6M | $22.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
UTMD // BETA —